WO2007079715A3 - Neue lysolipin derivate - Google Patents

Neue lysolipin derivate Download PDF

Info

Publication number
WO2007079715A3
WO2007079715A3 PCT/DE2006/002324 DE2006002324W WO2007079715A3 WO 2007079715 A3 WO2007079715 A3 WO 2007079715A3 DE 2006002324 W DE2006002324 W DE 2006002324W WO 2007079715 A3 WO2007079715 A3 WO 2007079715A3
Authority
WO
WIPO (PCT)
Prior art keywords
lysolipin
derivatives
novel
type
producing
Prior art date
Application number
PCT/DE2006/002324
Other languages
English (en)
French (fr)
Other versions
WO2007079715A2 (de
Inventor
Carsten Fischer
Andreas Hornung
Meike Holzenkaempfer
Stefan Pelzer
Horst Priefert
Ulf-Dietrich Renner
Silke Vierling
Sven-Eric Wohlert
Original Assignee
Combinature Biopharm Ag
Carsten Fischer
Andreas Hornung
Meike Holzenkaempfer
Stefan Pelzer
Horst Priefert
Ulf-Dietrich Renner
Silke Vierling
Sven-Eric Wohlert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Combinature Biopharm Ag, Carsten Fischer, Andreas Hornung, Meike Holzenkaempfer, Stefan Pelzer, Horst Priefert, Ulf-Dietrich Renner, Silke Vierling, Sven-Eric Wohlert filed Critical Combinature Biopharm Ag
Priority to DE112006003804T priority Critical patent/DE112006003804A5/de
Publication of WO2007079715A2 publication Critical patent/WO2007079715A2/de
Publication of WO2007079715A3 publication Critical patent/WO2007079715A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Die Erfindung betrifft neue Lysolipin Derivate, Verwendungen solcher Lysolipin Derivate, pharmazeutische Zusammensetzungen mit solchen Lysolipin Derivaten, Verfahren zur Herstellung solcher Lysolipin Derivate und Zwischenprodukte der Herstellung solcher Lysolipin Derivate.
PCT/DE2006/002324 2006-01-09 2006-12-21 Neue lysolipin derivate WO2007079715A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE112006003804T DE112006003804A5 (de) 2006-01-09 2006-12-21 Neue Lysolipin Derivate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006002427A DE102006002427A1 (de) 2006-01-09 2006-01-09 Neue Lysolipin Derivate
DE102006002427.3 2006-01-09

Publications (2)

Publication Number Publication Date
WO2007079715A2 WO2007079715A2 (de) 2007-07-19
WO2007079715A3 true WO2007079715A3 (de) 2007-09-20

Family

ID=38162240

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2006/002324 WO2007079715A2 (de) 2006-01-09 2006-12-21 Neue lysolipin derivate

Country Status (2)

Country Link
DE (2) DE102006002427A1 (de)
WO (1) WO2007079715A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5874463B2 (ja) * 2012-03-16 2016-03-02 住友化学株式会社 化合物および高分子化合物、並びに該高分子化合物を含む有機薄膜および有機半導体素子
NO341815B1 (en) 2016-04-22 2018-01-29 Marbileads New antimicrobial compound, a method of producing it, pharmaceutical compositions and uses in therapy

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4277478A (en) * 1975-05-20 1981-07-07 Ciba-Geigy Corporation Antibiotic and use thereof
DE19635642A1 (de) * 1996-09-03 1998-03-05 Knoell Hans Forschung Ev Neue Dihydrobenzo[a]naphthacenchinone, ein Verfahren zu ihrer Herstellung und Verwendung derselben
WO2006032232A2 (de) * 2004-09-24 2006-03-30 Combinature Biopharm Ag Neuer lysolipin biosynthesegencluster

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08333232A (ja) * 1995-06-07 1996-12-17 Kao Corp 美白剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4277478A (en) * 1975-05-20 1981-07-07 Ciba-Geigy Corporation Antibiotic and use thereof
DE19635642A1 (de) * 1996-09-03 1998-03-05 Knoell Hans Forschung Ev Neue Dihydrobenzo[a]naphthacenchinone, ein Verfahren zu ihrer Herstellung und Verwendung derselben
WO2006032232A2 (de) * 2004-09-24 2006-03-30 Combinature Biopharm Ag Neuer lysolipin biosynthesegencluster

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BOCKHOLT, H. ET AL.: "BIOSYNTHETIC STUDIES ON THE XANTHONE ANTIBIOTICS LYSOLIPINS X AND I", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, US, vol. 59, no. 8, 1994, pages 2064 - 2069, XP002907290, ISSN: 0022-3263 *
DOBLER, M. ET AL.: "METABOLITES OF MICROORGANISMS 162ND COMMUNICATION. THE CRYSTAL AND MOLECULAR STRUCTURE O LYSOLIPIN I", HELVETICA CHIMICA ACTA, VERLAG HELVETICA CHIMICA ACTA. BASEL, CH, vol. 60, no. 19, 1977, pages 178 - 185, XP002907291, ISSN: 0018-019X *

Also Published As

Publication number Publication date
DE102006002427A1 (de) 2007-07-12
WO2007079715A2 (de) 2007-07-19
DE112006003804A5 (de) 2008-12-18

Similar Documents

Publication Publication Date Title
WO2007093627A3 (de) Biozide zusammensetzung
WO2008046581A3 (de) Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln
WO2007139871A3 (en) Methods and materials for making simvastatin and related compounds
WO2007144424A3 (en) Processes for production of a starch hydrolysate
WO2010069532A8 (en) Antibodies against human angiopoietin 2
WO2006114520A3 (fr) Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
WO2010031720A3 (en) Novel antibody formulation
WO2010049454A3 (en) Antimicrobial composition from copepods
WO2009135646A3 (en) Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
WO2008149345A3 (en) Tri-aryl compounds and compositions comprising the same
WO2008017346A3 (de) Ascorbinsäurederivate, verwendung zur funktionalisierung von matrices
WO2009115084A3 (de) Pyrrolopyrimidin-derivate und deren verwendungen
WO2007115210A3 (en) Non-starchy rice bran polysaccharides
WO2010015657A3 (en) Alkoxypyrazoles and the process for their preparation
WO2009051460A3 (en) Peptide coupled ascorbic acid derivatives
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2008083130A3 (en) Amorphous and crystalline form a of carvedilol phosphate
WO2008065282A3 (fr) Pyrazoles substituees, compositions les contenant, procede de fabrication et utilisation
IL186862A0 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
WO2009051417A3 (en) Phenanthrene lactam derivatives having anticancer activity and method for the preparation thereof
WO2008137134A3 (en) Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
WO2007098273A3 (en) Novel crystalline forms of armodafinil and preparation thereof
WO2011067236A3 (de) Raltegravir-polymorphe
WO2007125521A3 (en) Polymorphic form of zoledronic acid and processes for their preparation
WO2006122777A3 (de) Verwendung von 2,5-disubstituierten thiazol-4-on-derivaten in arzneimitteln

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06846954

Country of ref document: EP

Kind code of ref document: A2

REF Corresponds to

Ref document number: 112006003804

Country of ref document: DE

Date of ref document: 20081218

Kind code of ref document: P

122 Ep: pct application non-entry in european phase

Ref document number: 06846954

Country of ref document: EP

Kind code of ref document: A2